Ethema Health Corp (GRST)

[Bubae]

There has been an enormous accumulation at 6 and I'm surprised more didn't bail to break even on this run. There is currently roughly $750K eligible to convert at .001 and there may be more. So who really wants 8s or 9s hoping to flip. If you will have trouble getting 8s or 9s sold why buy 7s? The Leonite $745K June note has a conversion price of .01, but adjusts to the lowest subsequent dilutive share price. So if they convert anything at .001, the Leonite$745K note conversion price drops to .001.

Now they say that they hope to sell up to 4 billion shares at .0012 with the offering. I take their word for very little given their history, but when they say they are going to dilute the living crap out of this, I believe them.


The balance on the Leonite note that partially converted February 28th is $173K, converts at .001.

For the quarterly period ended March 31, 2022
https://sec.report/Document/0001903596-22-000301/

[color=red]10. Short-term Convertible Notes (continued)
Leonite Capital, LLC (continued)

On February 28, 2022, in terms of a conversion notice, Leonite converted the principal sum of $149,250 of the Leonite Note into 150,000,000 shares of common stock at a conversion price of $0.0010 per share.


Joshua Bauman

On October 21, 2021, the Company entered into a Securities Purchase Agreement with Joshua Bauman (“Bauman”), pursuant to which the Company issued a senior secured convertible promissory note in the aggregate principal amount of $150,000, including an original issue discount of $16,250. The note bears interest at 11.0% per annum, which is guaranteed and earned in full on issue date and matures on October 21, 2022. The note may be prepaid at certain prepayment penalties and is convertible into shares of common stock at a conversion price at the option of the holder at $0.001 per share, adjusted for anti-dilution provisions.

On July 12, 2020, the Company entered into a Senior Secured Convertible Note agreement with Leonite for $440,000 with an original issue discount of $40,000 for gross proceeds of $400,000, the initial tranche advanced will be for cash of $200,000 plus the OID of $20,000, the remaining advances will be at the discretion of the Leonite. The loan bears interest at 6.5% per annum and matures on June 12, 2021. The Company is required to make monthly payments of the accrued interest on the advances made.

Ethema Continues to Reduce Debt
March 01, 2022 10:19 ET | Source: Ethema Health Corporation
https://www.globenewswire.com/en/news-release/2022/03/01/2394545/0/en/Ethema-Continues-to-Reduce-Debt.html

...The Company entered into a forbearance agreement with Leonite Capital Inc. (“Leonite”) for their note dated July 12, 2020 which limits certain collection activities for payment defaults until June 28, 2022. The current conversion price being employed on the note is $.001 per share...